Your browser doesn't support javascript.
loading
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study).
Hizal, Mutlu; Sendur, Mehmet An; Yasar, Hatime Arzu; Bir Yucel, Kadriye; Arslan, Cagatay; Ucar, Gokhan; Karakaya, Serdar; Taban, Hakan; Kucukarda, Ahmet; Erturk, Ismail; Bilgin, Burak; Yildirim, Nuriye; Demirci, Umut; Kilickap, Saadettin; Cicin, Irfan; Karadurmus, Nuri; Yalcin, Bulent; Ürün, Yüksel.
Affiliation
  • Hizal M; Department of Medical Oncology, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey.
  • Sendur MA; Department of Medical Oncology, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey.
  • Yasar HA; Medical Oncology Department, Ankara University School of Medicine, Ankara, Turkey.
  • Bir Yucel K; Ankara University Cancer Research Institute, Ankara, Turkey.
  • Arslan C; Internal Medicine Department, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Ucar G; Department of Internal Medicine and Medical Oncology, Bahcesehir University Faculty of Medicine, Istanbul, Turkey.
  • Karakaya S; Medical Oncology Department, University of Health Sciences, Ankara Numune Education and Research Hospital, Ankara, Turkey.
  • Taban H; Medical Oncology Department, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey.
  • Kucukarda A; Medical Oncology Department, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Erturk I; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
  • Bilgin B; Medical Oncology Department, University of Health Sciences, Gülhane Education and Research Hospital, Ankara, Turkey.
  • Yildirim N; Department of Medical Oncology, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey.
  • Demirci U; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey.
  • Kilickap S; Medical Oncology Department, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey.
  • Cicin I; Medical Oncology Department, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Karadurmus N; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
  • Yalcin B; Medical Oncology Department, University of Health Sciences, Gülhane Education and Research Hospital, Ankara, Turkey.
  • Ürün Y; Department of Medical Oncology, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey.
J Oncol Pharm Pract ; 26(7): 1583-1589, 2020 Oct.
Article in En | MEDLINE | ID: mdl-32054412
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocytes / Carcinoma, Renal Cell / Kidney Neoplasms / Neutrophils Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2020 Type: Article Affiliation country: Turkey
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocytes / Carcinoma, Renal Cell / Kidney Neoplasms / Neutrophils Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2020 Type: Article Affiliation country: Turkey